Net Cash Provided by (Used in) Operating Activities |
-1.96M |
USD |
-34.1% |
Q2 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
1.96M |
USD |
+1.58% |
Q2 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
200K |
USD |
|
Q2 2022 |
Q1 2024 |
Common Stock, Shares Authorized |
900M |
shares |
0% |
Q2 2024 |
Q1 2025 |
Common Stock, Shares, Issued |
579M |
shares |
+6039% |
Q2 2024 |
Q1 2025 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
855K |
USD |
-17% |
Q2 2024 |
Q1 2025 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
8.24K |
USD |
-67.5% |
Q2 2024 |
Q1 2025 |
Deferred Tax Assets, Valuation Allowance |
133K |
USD |
|
Q1 2024 |
FY 2024 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
|
Q1 2022 |
Q3 2023 |
Deferred Tax Assets, Gross |
3.53M |
USD |
+667% |
Q1 2024 |
FY 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
2.53M |
USD |
|
Q1 2024 |
FY 2024 |
Additional Paid in Capital |
33.7M |
USD |
+23.5% |
Q3 2023 |
Q2 2024 |
Amortization of Intangible Assets |
74.4K |
USD |
-28.2% |
Q2 2024 |
Q1 2025 |
Deferred Tax Assets, Net of Valuation Allowance |
133K |
USD |
|
Q1 2024 |
FY 2024 |
Interest Expense |
52.7K |
USD |
-53.1% |
Q4 2023 |
Q3 2024 |